Principia Biopharma announces $100M IPO

Principia Biopharma announces $100M IPO

Principia is a spinoff from Jack Taunton’s lab at UCSF.

Atreca Raises $125 Million

Atreca Raises $125 Million

Atreca was one of the first companies in Mission Bay Capital’s portfolio.

FDA Grants Breakthrough Therapy Designation for Concentric Analgesics’ CA-008 in Post-Surgical Pain

FDA Grants Breakthrough Therapy Designation for Concentric Analgesics’ CA-008 in Post-Surgical Pain

The drug is an alternative to opiates.

Synvitrobio rebrands & raises cash

Synvitrobio rebrands & raises cash

Under its new name, Tierra Biosciences, the company will focus on agricultural and biochemical products.

Newomics Closes $3.9M Series A Round

Newomics Closes $3.9M Series A Round

Newomics will use the funds to expand the team and commercialize its silicon-based multinozzle emitter array technology.

Pivot Bio aims to stem red tides

Pivot Bio aims to stem red tides

Pivot’s crop probiotics prevent the nitrate runoff that causes algal blight in waterways.

WuXi AppTec and Cyclica team to drive polypharmacology in drug discovery

WuXi AppTec and Cyclica team to drive polypharmacology in drug discovery

The collaboration will advance polypharmacology in drug discovery using AI-augmented technology.

Principia Biopharma files for an $86 million IPO

Principia Biopharma files for an $86 million IPO

Principia plans to list on the Nasdaq under the symbol PRNB.

$700 Million Bolt Threads May Have Cracked The Code On Spider Silk

$700 Million Bolt Threads May Have Cracked The Code On Spider Silk

Wary of failing in public, they worked in stealth at the QB3 Garage for 5 years.

Alector raises $133M to push neuro-immunology drugs into Alzheimer’s trials

Alector raises $133M to push neuro-immunology drugs into Alzheimer’s trials

With this much investor interest, the round keeps Alector's options open, CBO Sabah Oney says.